F. Sormani

Quality of life in patients on active surveillance for bladder cancer

Rodolfo Hurle, Roberto Contieri, F. Sormani, Massimo Lazzeri et autres

The data that support the findings of this study are available from the corresponding author upon reasonable request.

it (code pays fourni par la source)

Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study—On behalf of the Young Academic Urology (YAU) Urothelial Working Group

Roberta Corvino, Giuseppe Basile, Valerio Santarelli, Vincenzo Asero et autres

BACKGROUND AND OBJECTIVE: Patients undergoing radical cystectomy (RC) for bladder cancer may present with synchronous or metachronous upper tract urothelial carcinoma (UTUC). These scenarios may differ in oncological outcomes and surgical complexity. This study sought to compare oncologic and perioperative outcomes in …

it, gb, pl, jp, es, at, ch, nl, hk, de, fr, ca, us (code pays fourni par la source)

Xpert bladder cancer detection and monitor in urothelial carcinoma: systematic review and meta-analysis

Ludovica Cella, Vittorio Fasulo, Alessandro Uleri, Andrea Piccolini et autres

Xpert Bladder Cancer (BC) is an mRNA-based urine assay for diagnosis and surveillance of urothelial carcinoma. Although previous meta-analyses have examined Xpert, none has evaluated its accuracy in both BC detection and non-muscle-invasive bladder cancer (NMIBC) surveillance, while also exploring its potential …

it, fr (code pays fourni par la source)

IP20-27 LONGITUDINAL ASSESSMENT OF PATIENT-REPORTED QUALITY OF LIFE AND MENTAL HEALTH DURING ACTIVE SURVEILLANCE FOR LOW-GRADE NMIBC

Marco Paciotti, Mario Tiscione, F. Sormani, Andrea Piccolini et autres

PD09-11 UPDATE FROM THE BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT FOR LOW-GRADE BLADDER TUMORS: LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS UNDER ACTIVE SURVEILLANCE

Alessio Finocchiaro, Marco Paciotti, F. Sormani, Edoardo Beatrici et autres

IP26-23 PROGNOSTIC VALUE OF PREOPERATIVE SUV IN PATIENTS WHO UNDERWENT FOCAL THERAPY HIFU: EARLY PROSPECTIVE RESULTS FROM A SINGLE-CENTER COHORT

V. Mallia, A. Tallari, Vittorio Fasulo, Laura Evangelista et autres

Family awareness of genetic risk in affected Caucasian ancestry members with bladder cancer (BC) associated with germline variants in DNA‐repair genes (gDRGs).

Giovanni Lughezzani, R. Hurle, Paolo Casale, Alberto Saita et autres

868 Background: The aim of this study is to evaluate the awareness of Bladder Cancer (BC) in families with at least one affected Caucasian ancestry member harbouring germline variants in DNA‐repair genes (gDRGs). Methods: Data were collected from a prospective, monocentric cohort …

it (code pays fourni par la source)

Longitudinal assessment of patient-reported quality of life and mental health during active surveillance for low-grade NMIBC.

Marco Paciotti, F. Sormani, Andrea Piccolini, Mario Tiscione et autres

727 Background: While transurethral resection of bladder tumor (TURBT) remains the gold-standard treatment for non–muscle-invasive bladder cancer (NMIBC), there is growing interest in de-intensification strategies aimed at reducing the patient burden of repeated procedures and the overall economic impact of the disease. …

it (code pays fourni par la source)

Germline DNA repair gene (gDRG) variants in BCG un-responsive patients: A potential genetic implication for risk stratification and target therapy.

R. Hurle, Massimo Lazzeri, Alberto Saita, NicolòMaria Buffi et autres

808 Background: The introduction of the “BCG-unresponsive” definition by the U.S. Food and Drug Administration (FDA) has provided a structured framework for classifying patients unlikely to benefit from BCG therapy, accelerating the approval of novel therapeutic agents. There is an urgent need …

it (code pays fourni par la source)

Germline Homologous Recombination Repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications

F. Sormani, R. Hurle, Anita Capalbo, G. Lughezzani et autres

Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications

Rodolfo Hurle, Anita Capalbo, Giovanni Lughezzani, Nicolò Maria Buffi et autres

Abstract Objective The contribution of germline DNA repair gene (gDRG) variants to bladder cancer (BC) susceptibility and progression is still poorly defined, particularly in European populations. This study aims to evaluate the prevalence and clinical implications of germline homologous recombination repair (HRR) …

it (code pays fourni par la source)

Extraperitoneal ureteroplasty outcomes using the da Vinci Single Port system: A single center initial experience

F. De Carne, A. Finocchiaro, F. Sormani, Roberto Trovato et autres